Home › NDC Lookup › RxCUI directory › RxCUI 2719470

Dicyclomine hydrochloride 40 MG Oral Tablet — RxCUI 2719470

RxNorm drug concept · Semantic clinical drug
RxCUI 2719470 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2719470
Official nameDicyclomine hydrochloride 40 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped3
Package NDCs mapped10
Reported Medicaid activity (SDUD)24,706 prescriptions · 44 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dicyclomine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Dicyclomine relaxes the overactive muscles in your intestines that cause IBS cramping and pain — it works both by blocking certain nerve signals and by directly calming the gut mus...
  • What exactly does dicyclomine do, and how quickly will I notice it working?
  • The most common ones are dizziness, dry mouth, and blurred vision — these showed up in a significant number of patients in clinical trials. You might also notice some nausea, drows...
  • What are the most common side effects I should expect?
📖 Read our full Dicyclomine guide →

🕸️ Concept Web — How Dicyclomine hydrochloride 40 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Dicyclomine hydrochloride 40 MG Oral Tablet RxCUI 2719470

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Dicyclomine 3361
    • Dicyclomine hydrochloride 152021
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Dicyclomine Oral Tablet 371817
    • Dicyclomine hydrochloride Oral Tablet 2649127
    • Dicyclomine Oral Product 1151168
    • Dicyclomine Pill 1151169
    • Dicyclomine hydrochloride Oral Product 2659854
    • Dicyclomine hydrochloride Pill 2662305
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Dicyclomine hydrochloride 40 MG 2719469

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Dicyclomine hydrochloride 40 MG SCDC · 2719469
  • Dicyclomine Oral Tablet SCDF · 371817
  • Dicyclomine hydrochloride Oral Tablet SCDFP · 2649127
  • Dicyclomine Oral Product SCDG · 1151168
  • Dicyclomine Pill SCDG · 1151169
  • Dicyclomine hydrochloride Oral Product SCDGP · 2659854
  • Dicyclomine hydrochloride Pill SCDGP · 2662305

📦 FDA Products & Package NDCs

3 products · 10 package NDCs
10 package NDCs map to RxCUI 2719470 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72888-0119-00 1000 TABLET in 1 BOTTLE (72888-119-00) Dicyclomine hydrochloride Advagen Pharma Ltd., 2022-12-14
72888-0119-01 100 TABLET in 1 BOTTLE (72888-119-01) Dicyclomine hydrochloride Advagen Pharma Ltd., 2022-12-14
72888-0119-05 500 TABLET in 1 BOTTLE (72888-119-05) Dicyclomine hydrochloride Advagen Pharma Ltd., 2022-12-14
72888-0119-30 30 TABLET in 1 BOTTLE (72888-119-30) Dicyclomine hydrochloride Advagen Pharma Ltd., 2022-12-14
72888-0198-00 1000 TABLET in 1 BOTTLE (72888-198-00) Dicyclomine hydrochloride Advagen Pharma Ltd., 2025-03-25
72888-0198-01 100 TABLET in 1 BOTTLE (72888-198-01) Dicyclomine hydrochloride Advagen Pharma Ltd., 2025-03-25
72888-0198-05 500 TABLET in 1 BOTTLE (72888-198-05) Dicyclomine hydrochloride Advagen Pharma Ltd., 2025-03-25
72888-0198-12 120 TABLET in 1 BOTTLE (72888-198-12) Dicyclomine hydrochloride Advagen Pharma Ltd., 2025-03-25
72888-0198-30 30 TABLET in 1 BOTTLE (72888-198-30) Dicyclomine hydrochloride Advagen Pharma Ltd., 2026-02-17
73352-0119-60 60 TABLET in 1 BOTTLE (73352-119-60) Dicyclomine hydrochloride Trifluent Pharma, LLC 2025-07-14
Observed labelers: Advagen Pharma Ltd., (9) · Trifluent Pharma, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.